Browse by:
Research & Development

Alexion to sell enzyme replacement therapy in Europe

Cheshire drug maker Alexion Pharmaceuticals said it has been given clearance to begin selling its long-term enzyme replacement therapy drug, Kanuma, in Europe.

ADVERTISEMENTS
Copyright 2016 New England Business Media